Rectal Cancer
📧 Sign up to get email alerts when something new happens for Rectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: "Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer" [NA]
This clinical trial update reports termination of a study evaluating pelvic floor prehabilitation with biofeedback to reduce the severity of…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer [Phase 2]
A Phase 2 study evaluating CTX-009 in adults with metastatic colorectal cancer has completed, according to the trial record.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment [Phase 2]
Phase 2 clinical trial evaluating zanidatamab given before surgery for HER2-positive colon and rectal cancer planned for curative-intent tre…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision [NA]
This clinical trial update reports ongoing optimization and standardization of a single-port robotic transanal minimally invasive surgery ap…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.
A clinical trial evaluating the diagnostic accuracy and prognostic value of 18F-FDG PET-CT in the follow-up of patients with colorectal canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial. [Phase 2, Phase 3]
This is a clinical trial update for a randomized controlled study evaluating antegrade intestinal fluid reinfusion to prevent Low Anterior R…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment [Phase 2]
Clinical trial update announcing a phase 2 study of lenvatinib in combination with pembrolizumab for anal or rectal cancer that progressed a…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary [NA]
This clinical trial focuses on developing an electronic diary and personalized care pathways to address bowel symptoms in rectal cancer pati…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
A clinical trial evaluating metabolomics as a predictor of treatment response and toxicities in rectal cancer. Sponsored by Chang Gung Memor…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer [Phase 1]
Phase 1 trial update evaluating TAS-102 (trifluridine/tipiracil) with concurrent radiation for untreated resectable stage II-III rectal canc…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Multicenter Phase II Study of Transanal TME (taTME) [NA]
A multicenter Phase II study is evaluating transanal total mesorectal excision (taTME) for rectal cancer; the trial is currently active but …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial [Phase 2]
This is a Phase II, multi-center randomized trial protocol evaluating neoadjuvant moderately hypofractionated radiotherapy with chemotherapy…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer [Phase 2]
Phase II trial update evaluating camrelizumab with long-course chemoradiotherapy as total neoadjuvant therapy for locally advanced rectal ca…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer [Phase 3]
Phase 3 trial evaluating neoadjuvant CAPOX with or without Pucotenlimab and selective radiotherapy for locally advanced rectal cancer is cur…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer [Phase 3]
A Phase 3 clinical trial comparing neoadjuvant chemotherapy with excision and observation versus chemoradiotherapy for rectal cancer is curr…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer [Phase 2]
A Phase 2 clinical trial assesses short-course radiotherapy or long-course chemoradiation followed by mFOLFOXIRI consolidation chemotherapy …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer [Phase 2]
Phase 2 trial evaluating short-course radiotherapy in combination with nal-IRI (nanoliposomal irinotecan), capecitabine, and camrelizumab fo…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer [Phase 2]
Clinical Trial Update describes a Phase 2 study evaluating a therapy adapted for high-risk and low-risk HIV-associated anal cancer, with the…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment
This update describes a multidimensional clinical study to develop an MRI-based framework to predict pathological complete response after ne…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer [Phase 2]
Phase 2 trial evaluating nivolumab and ipilimumab with short-course radiation for locally advanced rectal cancer; the study is currently act…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial comparing pre-operative 3-D conformal radiation therapy (3-DCRT) versus intensity-modulated radiation thera…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin [NA]
Clinical trial evaluating Mepilex Lite dressings for treating acute radiation dermatitis of the anal canal skin in rectal cancer patients un…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]
This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers underg…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Registry Maastro Applicator
Clinical trial registry entry for the Maastro Applicator in rectal cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Total Neoadjuvant Therapy in Rectal Cancer [Phase 2]
A Phase 2 clinical trial is evaluating total neoadjuvant therapy for rectal cancer. The study is currently recruiting.